Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IMMUNE GLOBULIN NOS Cause Peripheral swelling? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Peripheral swelling have been filed in association with IMMUNE GLOBULIN NOS. This represents 0.2% of all adverse event reports for IMMUNE GLOBULIN NOS.

5
Reports of Peripheral swelling with IMMUNE GLOBULIN NOS
0.2%
of all IMMUNE GLOBULIN NOS reports
0
Deaths
4
Hospitalizations

How Dangerous Is Peripheral swelling From IMMUNE GLOBULIN NOS?

Of the 5 reports, 4 (80.0%) required hospitalization.

Is Peripheral swelling Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IMMUNE GLOBULIN NOS. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does IMMUNE GLOBULIN NOS Cause?

Drug ineffective (963) Off label use (675) Drug ineffective for unapproved indication (266) Condition aggravated (207) Product use in unapproved indication (143) Therapy non-responder (130) Treatment failure (121) Septic shock (95) Diarrhoea (92) Maternal exposure during pregnancy (83)

What Other Drugs Cause Peripheral swelling?

ADALIMUMAB (13,837) ETANERCEPT (12,654) METHOTREXATE (10,632) TOCILIZUMAB (8,030) TOFACITINIB (7,830) ABATACEPT (7,561) LEFLUNOMIDE (7,254) LENALIDOMIDE (6,364) HYDROXYCHLOROQUINE (6,128) RITUXIMAB (5,977)

Which IMMUNE GLOBULIN NOS Alternatives Have Lower Peripheral swelling Risk?

IMMUNE GLOBULIN NOS vs IMPLANON IMMUNE GLOBULIN NOS vs INAVOLISIB IMMUNE GLOBULIN NOS vs INCIVEK IMMUNE GLOBULIN NOS vs INCIVO IMMUNE GLOBULIN NOS vs INCLISIRAN

Related Pages

IMMUNE GLOBULIN NOS Full Profile All Peripheral swelling Reports All Drugs Causing Peripheral swelling IMMUNE GLOBULIN NOS Demographics